Work Here?
Industries
Biotechnology
Healthcare
Company Size
10,001+
Company Stage
IPO
Total Funding
N/A
Headquarters
Madison, Wisconsin
Founded
1967
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$0
Below
Industry Average
Funded Over
1 Rounds
Quest Diagnostics to spend $40 Million to occupy 96,000 square feet of space in Lewisville Texas. Quest Diagnostics to spend $40 Million to occupy 96,000 square feet of space in Lewisville Texas.Lewisville, Texas — According to state and local development sources, Quest Diagnostics plans to invest $40,000,000.00 to build out 96,000 square feet of new space in Lewisville. The company plans to occupy the new space at 2777 Lake Vista Drive Suite 100 in Lewisville, on or about February 1, 2026. According to the company website Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the worlds largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives
Deal! Concept of collaboration in medicine. Close up photo of two doctors' handshake on gray background. Quest Diagnostics on Monday announced it completed its previously announced acquisition of select assets of University Hospitals, one of the nation’s leading nonprofit health systems and academic medical centers. Financial terms were not disclosed
Quality and regulatory veteran of Getinge, BD and JJ joins the Quest Diagnostics executive team SECAUCUS, N.J., Jan. 8, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that Adrienne L. Brott, an accomplished quality and regulatory affairs healthcare leader, has been named senior vice president and chief quality and regulatory affairs officer
SECAUCUS, N.J., Jan. 8, 2025 /PRNewswire/ - Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that Adrienne L. Brott, an accomplished quality and regulatory affairs healthcare leader, has been named senior vice president and chief quality and regulatory affairs officer.
Tampa, Florida, United States, December 2024 - Michael Noviello has joined Quest Diagnostics as the Senior Director - Human Resources Business Partner, bringing with him a wealth of experience in HR leadership and transformation.
Find jobs on Simplify and start your career today
Industries
Biotechnology
Healthcare
Company Size
10,001+
Company Stage
IPO
Total Funding
N/A
Headquarters
Madison, Wisconsin
Founded
1967
Find jobs on Simplify and start your career today